The New York Heart Association Classes and functional status: what are we really measuring?
Claiborne Miller-Davis, Sue Marden, Nancy Kline Leidy
https://pubmed.ncbi.nlm.nih.gov/16863893/Actively Recruiting
Led by National University of Ireland, Galway, Ireland · Updated on 2026-04-15
346
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are evaluating whether follow-up care using virtual wards can reduce hospital stays for patients recently hospitalized with heart failure. The study compares virtual ward follow-up with usual care to assess if it decreases heart failure hospitalizations and all-cause mortality at three, six, and twelve months. The research also examines cost-effectiveness, medication use, and quality of life improvements. The study is a randomized, controlled trial conducted at multiple centers in Ireland with patients aged 18 and older. Participants are randomized into two groups standard care and telemonitoring. Both groups have an initial face-to-face appointment within two weeks of hospital discharge. The standard care group receives follow-up with nurse-led face-to-face or phone appointments at weeks 6 and 12. The telemonitoring group receives a tablet, weight scale, and blood pressure monitor if needed and provides daily biometric data and symptom reports. Their follow-up includes scheduled phone or video calls at weeks 4, 6, 8, and 12, with extra visits as required. During the study, participants undergo regular assessments to monitor hospital admissions, mortality, medication use, and quality of life. Clinical events are reviewed by a committee unaware of group assignments. Data collection includes biometric monitoring and symptom tracking for the telemonitoring group. The study duration includes follow-up at three, six, and twelve months, with outcomes evaluated through in-person visits and telephone or virtual appointments. The aim is to understand the impact of virtual ward care on heart failure management over time.
CONDITIONS
Heart Failure Virtual Ward Research Study
D
David Tiernan, MD
N
Nuria Farre, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National University of Ireland, Galway, Ireland
Lead Sponsor
Health Service Executive, Ireland
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - 12 weeks
Participants receive either telemonitoring support or standard care after hospital discharge for heart failure. Telemonitoring participants provide daily biometric data and report symptoms, with scheduled virtual and phone appointments. Standard care participants have scheduled face-to-face follow-up appointments.
6 structured appointments including face-to-face, phone calls, and videoconferences for telemonitoring group; 3 face-to-face appointments for standard care group
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Claiborne Miller-Davis, Sue Marden, Nancy Kline Leidy
https://pubmed.ncbi.nlm.nih.gov/16863893/National University of Ireland, Galway, Ireland
Lead Sponsor
Health Service Executive, Ireland
Collaborating Sponsor